{"id":"NCT00784368","sponsor":"Janssen Pharmaceutical K.K.","briefTitle":"A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection","officialTitle":"A Pharmacokinetic Study of JK1211 in Patients With Systemic Fungal Infection (SFI) and Patients With Febrile Neutropenia (FN) Suspected of Fungal Infection.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2009-04","completion":"2009-05","firstPosted":"2008-11-03","resultsPosted":"2013-07-25","lastUpdate":"2013-07-25"},"enrollment":55,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Mycoses","Candidiasis","Aspergillosis","Cryptococcosis","Blastomycosis","Histoplasmosis","Neutropenia"],"interventions":[{"type":"DRUG","name":"ITCZ Oral Solution","otherNames":["Itrizole Oral Solution 1%, JK1211"]},{"type":"DRUG","name":"ITCZ-IV","otherNames":[]}],"arms":[{"label":"SFI (ITCZ Oral Solution Monotherapy)","type":"EXPERIMENTAL"},{"label":"SFI (Switched Treatment)","type":"EXPERIMENTAL"},{"label":"FN (Switched treatment)","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the pharmacokinetics (how the drug is absorbed in the body, distributed within the body, and how it is removed from the body over time) of itraconazole (ITCZ) oral solution in participants with Systemic Fungal Infection (SFI) and those with febrile (with fever) neutropenia (FN, decrease in white blood cells) suspected of fungal infection.","primaryOutcome":{"measure":"Maximum Plasma Itraconazole Concentration (Cmax)","timeFrame":"Day 85 for SFI (ITCZ Oral Solution Monotherapy); and Day 99 for SFI and FN Switched treatment","effectByArm":[{"arm":"SFI (ITCZ Oral Solution Monotherapy)","deltaMin":2.9,"sd":1.48},{"arm":"SFI (Switched Treatment)","deltaMin":2.3,"sd":1.12},{"arm":"FN (Switched Treatment)","deltaMin":1.79,"sd":0.682}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_JNJ_6051&studyid=418&filename=CR014299_CSR.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":16},"commonTop":["Diarrhoea","Hypokalaemia","Liver disorder","Beta 2 microglobulin urine increased","Beta-N-acetyl-D-glucosaminidase increased"]}}